Panic Disorder

• CLINICAL_TRIALS trial_result · 2024-08-21
  Clinical Trial Update: CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT [NA]

  A randomized trial comparing CBT that targets anxiety sensitivity with disorder-specific CBT has completed.

• FDA approval · 2024-08-12
  FDA Approved: VENLAFAXINE — Supplemental Application (Ascend Laboratories, LLC)

  The FDA approved a supplemental application for venlafaxine submitted by Ascend Laboratories, LLC.

• CLINICAL_TRIALS research · 2024-07-30
  Clinical Trial Update: Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room [NA]

  An update on a clinical trial led by Indiana University evaluating patient-centered treatment for anxiety after low-risk chest pain in the e…

• FDA label_change · 2024-06-12
  FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE submitted by Zydus Lifesciences Limited, resulting in changes to the pr…

• FDA approval · 2024-06-06
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approved Alembic Pharmaceuticals' Venlafaxine hydrochloride as an original-application generic (ANDA 217767). Venlafaxine HCl is indicat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-05-13
  Clinical Trial Update: Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety [NA]

  This study has completed a pragmatic trial evaluating collaborative care for depression or anxiety in cardiac inpatients. It targets patient…

• CLINICAL_TRIALS research · 2024-05-09
  Clinical Trial Update: Clinical Trial of a Group Self-management Support Program for Anxiety Disorders [NA]

  The trial is active but not recruiting for a group self-management support program targeting anxiety disorders, with listed conditions inclu…

• FDA approval · 2024-05-02
  FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application for the generic fluoxetine from Aurobindo Pharma Limited (ANDA213265).

• FDA approval · 2024-04-11
  FDA Approved: ALPRAZOLAM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for alprazolam submitted by Aurobindo Pharma Limited under an ANDA. This action indicates approval o…

• FDA approval · 2024-04-05
  FDA Approved: FLUOXETINE — Original Application (Strides Pharma Science Limited)

  FDA approved an Original Application for a generic Fluoxetine from Strides Pharma Science Limited, enabling a generic version of fluoxetine …

• FDA approval · 2024-03-19
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)

  FDA approved a supplemental application for venlafaxine hydrochloride from Camber Pharmaceuticals, approving a new supplement to an existing…

• FDA approval · 2024-03-15
  FDA Approved: ALPRAZOLAM — Supplemental Application (Amneal Pharmaceuticals LLC)

  FDA approves Amneal Pharmaceuticals LLC's supplemental application for Alprazolam (generic) under ANDA078387, signaling a supplemental appro…

• FDA approval · 2024-02-02
  FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

  The FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, Inc., resulting in approval of a gener…

• FDA approval · 2024-01-30
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)

  The FDA approved a supplemental application for venlafaxine hydrochloride from Epic Pharma, LLC, supporting the approval of a generic produc…

• FDA approval · 2024-01-19
  FDA Approved: PAROXETINE — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Paroxetine by ANI Pharmaceuticals, Inc., indicating approval of a generic product under ANDA 215…

• FDA approval · 2024-01-09
  FDA Approved: FLUOXETINE — Supplemental Application (Vensun Pharmaceuticals, Inc.)

  FDA approved a supplemental application for fluoxetine hydrochloride from Vensun Pharmaceuticals, Inc., granting approval of a generic fluox…

• FDA approval · 2024-01-03
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited, confirming approval of the generic prod…

• FDA approval · 2024-01-03
  FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' supplemental application for fluoxetine hydrochloride.

• FDA approval · 2023-12-19
  FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)

  FDA approved a supplemental application for fluoxetine by Alembic Pharmaceuticals Limited.

• FDA approval · 2023-11-21
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for venlafaxine hydrochloride extended-release (Chartwell RX, LLC), reflecting an approved update to…

• FDA approval · 2023-11-21
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)

  The FDA approved a supplemental application for venlafaxine hydrochloride from Granules Pharmaceuticals Inc., authorizing an additional form…

• FDA approval · 2023-11-20
  FDA Approved: FLUOXETINE — Supplemental Application (Endo USA, Inc.)

  The FDA approved a supplemental application for fluoxetine submitted by Endo USA, Inc., resulting in regulatory changes to the product's sta…

• FDA approval · 2023-11-15
  FDA Approved: FLUOXETINE — Supplemental Application (Micro Labs Limited)

  FDA approved a supplemental application for fluoxetine (generic) from Micro Labs Limited under an ANDA.

• FDA approval · 2023-11-01
  FDA Approved: VENLAFAXINE — Supplemental Application (Zydus Lifesciences Limited)

  FDA granted supplemental approval for venlafaxine from Zydus Lifesciences Limited, signaling an approved modification to an existing generic…

• FDA approval · 2023-10-18
  FDA Approved: ALPRAZOLAM — Supplemental Application (Natco Pharma USA LLC)

  FDA approved a supplemental application for Alprazolam from Natco Pharma USA LLC under an ANDA, updating the regulatory status of the produc…